Nanoparticles for the Treatment of Inflammatory Conditions

NanomedicineAhead of Print Journal WatchNanoparticles for the treatment of inflammatory conditionsChristina Janko, Mehtap Civelek, Iwona Cicha, Helmut Spielvogel, Harald Unterweger & Christoph AlexiouChristina Janko https://orcid.org/0000-0001-5705-6329Department of Otorhinolaryngology, Head & Neck Surgery, Section of Experimental Oncology & Nanomedicine, Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glueckstr. 10a, Erlangen, 91054, Germany, Mehtap CivelekDepartment of Otorhinolaryngology, Head & Neck Surgery, Section of Experimental Oncology & Nanomedicine, Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glueckstr. 10a, Erlangen, 91054, Germany, Iwona Cicha https://orcid.org/0000-0002-7399-5307Department of Otorhinolaryngology, Head & Neck Surgery, Section of Experimental Oncology & Nanomedicine, Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glueckstr. 10a, Erlangen, 91054, Germany, Helmut SpielvogelDepartment of Otorhinolaryngology, Head & Neck Surgery, Section of Experimental Oncology & Nanomedicine, Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glueckstr. 10a, Erlangen, 91054, Germany, Harald Unterweger https://orcid.org/0000-0002-8335-0692Department of Otorhinolaryngology, Head & Neck Surgery, Section of Experimental Oncology & Nanomedicine, Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glueckstr. 10a, Erlangen, 91054, Germany & Christoph Alexiou *Author for correspondence: E-mail Address: c.alexiou@web.dehttps://orcid.org/0000-0003-2220-6790Department of Otorhinolaryngology, Head & Neck Surgery, Section of Experimental Oncology & Nanomedicine, Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Glueckstr. 10a, Erlangen, 91054, GermanyPublished Online:17 Jan 2024https://doi.org/10.2217/nnm-2023-0324AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: cytokine stormdrug deliveryhypertensioninflammationischemia–reperfusion injurynanosystemsperiodontitispneumoniaReferences1. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat. Rev. Gastroenterol. Hepatol. 12(12), 720–727 (2015).MedlineGoogle Scholar2. Shah SC, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease: mechanisms and management. Gastroenterology 162(3), 715–730.e3 (2022).MedlineGoogle Scholar3. Wu Q, Pennini ME, Bergmann JN et al. Applying lessons learned from COVID-19 therapeutic trials to improve future ALI/ARDS trials. Open Forum Infect. Dis. 9(8), ofac381 (2022).MedlineGoogle Scholar4. Leist SR, Dinnon KH 3rd, Schäfer A. A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice. Cell 183(4), 1070–1085.e12 (2020).Medline CASGoogle Scholar5. Li X, Liu Z, Gao T et al. Tea polyphenols protects tracheal epithelial tight junctions in lung during Actinobacillus pleuropneumoniae infection via suppressing TLR-4/MAPK/PKC-MLCK signaling. Int. J. Mol. Sci. 24(14), (2023).Google Scholar6. Ye Y, Warusawitharana H, Zhao H et al. Tea polyphenols attenuates inflammation via reducing lipopolysaccharides level and inhibiting TLR4/NF-κB pathway in obese mice. Plant Foods Hum. Nutr. 77(1), 105–111 (2022).Medline CASGoogle Scholar7. Bugger H, Pfeil K. Mitochondrial ROS in myocardial ischemia reperfusion and remodeling. Biochim. Biophys. Acta Mol. Basis Dis. 1866(7), 165768 (2020).Medline CASGoogle Scholar8. Ambrosini S, Montecucco F, Kolijn D et al. Methylation of the Hippo effector YAP by the methyltransferase SETD7 drives myocardial ischaemic injury: a translational study. Cardiovasc. Res. 118(17), 3374–3385 (2023).MedlineGoogle Scholar9. Liu S, Li K, Florencio LW et al. Gene therapy knockdown of Hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction. Sci. Transl. Med. 13(600), (2021).Google Scholar10. de Jesus AA, Canna SW, Liu Y, Goldbach-Mansky R. Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu. Rev. Immunol. 33, 823–874 (2015).MedlineGoogle Scholar11. Grant RA, Morales-Nebreda L, Markov NS et al. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. Nature 590(7847), 635–641 (2021).Medline CASGoogle Scholar12. Otsuka R, Seino KI. Macrophage activation syndrome and COVID-19. Inflamm. Regen. 40, 19 (2020).Medline CASGoogle Scholar13. Muñoz Aguilera E, Suvan J, Buti J et al. Periodontitis is associated with hypertension: a systematic review and meta-analysis. Cardiovasc. Res. 116(1), 28–39 (2020).MedlineGoogle Scholar14. Del Pinto R, Landi L, Grassi G et al. Hypertension and periodontitis: a joint report by the Italian Society of Hypertension (SIIA) and the Italian Society of Periodontology and Implantology (SIdP). High Blood Press. Cardiovasc. Prev. 28(5), 427–438 (2021).MedlineGoogle ScholarFiguresReferencesRelatedDetails Ahead of Print STAY CONNECTED Metrics Downloaded 0 times History Received 8 November 2023 Accepted 13 November 2023 Published online 17 January 2024 Information© 2024 Future Medicine LtdKeywordscytokine stormdrug deliveryhypertensioninflammationischemia–reperfusion injurynanosystemsperiodontitispneumoniaFinancial disclosureThe authors have no financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties.Competing interests disclosureThe authors have no competing interests or relevant affiliations with any organization or entity with an interest in or conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties.Writing disclosureNo writing assistance was utilized in the production of this manuscript.PDF download